IA
ASMB icon

IndexIQ Advisors’s Assembly Biosciences ASMB Stock Holding History

IndexIQ Advisors’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,651
Closed -$214K – 1325
2021
Q4 		$214K Sell
7,651
-494
-6% -$16.2K 0.01% 1023
2021
Q3 		$340K Buy
8,145
+816
+11% +$34.2K 0.01% 937
2021
Q2 		$341K Sell
7,329
-104
-1% -$5.15K 0.01% 929
2021
Q1 		$410K Buy
+7,433
New +$493K 0.01% 516

Other funds holding ASMB

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

IndexIQ Advisors's ASMB Position: Q1 2022 in Review

IndexIQ Advisors sold out of Assembly Biosciences (ASMB) in Q1 2022, closing a stake of 7,651 shares — an estimated $214K sold.

IndexIQ Advisors first reported a position in ASMB in Q1 2021 and held it in 4 quarters. The position peaked at $410K in Q1 2021. 54 funds tracked by Wall St. Rank hold ASMB as of Q1 2022.

  • IndexIQ Advisors reported no remaining Assembly Biosciences position as of Q1 2022 after selling out during the quarter.
  • IndexIQ Advisors sold 7,651 Assembly Biosciences shares in Q1 2022, an estimated $214K.
  • IndexIQ Advisors first reported a position in Assembly Biosciences in Q1 2021 and held it in 4 quarters.
  • IndexIQ Advisors's Assembly Biosciences position peaked at $410K in Q1 2021.
  • 54 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.